title: Issues Regarding the Use of Heparin Following Streptokinase Therapy.
abstract: The success of thrombolytic therapy is dependent upon the balance of fibrinolytic activity and procoagulant activity. Streptokinase produces fibrin degradation products that have anticoagulant effects and may potentially protect against reocclusion. However, streptokinase also activates platelets and thrombin, and the prothrombotic effects may be more marked than after administration of recombinant tissue plasminogen activator (rt-PA). Administration of high-dose, delayed subcutaneous heparin after streptokinase and aspirin has been shown to have some benefits and some risks. The benefits and risks of adding intravenous heparin to aspirin and streptokinase have not been clearly defined.
authors.affiliation: Coronary Care and Cardiovascular Research, Green Lane Hospital, Auckland, New Zealand.
authors.initials: HD
authors.lastname: White
authors.initials: S
authors.lastname: Yusuf